Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Theranostics

Showing results (521-530 of 5,522) with videos related to

Pageof 553
Sort By:
Theranostics|January 3, 2017
Comparison of <sup>68</sup>Ga-HBED-CC PSMA-PET/CT and multiparametric MRI for gross tumour volume detection in patients with primary prostate cancer based on slice by slice comparison with histopathologyConstantinos Zamboglou, Vanessa Drendel, Cordula A Jilg, et al.
Theranostics|January 3, 2017
Systemic siRNA Delivery with a Dual pH-Responsive and Tumor-targeted Nanovector for Inhibiting Tumor Growth and Spontaneous Metastasis in Orthotopic Murine Model of Breast CarcinomaBo Fan, Lin Kang, Liqing Chen, et al.
Theranostics|January 3, 2017
The Landscape of Clinical Trials Evaluating the Theranostic Role of PET Imaging in Oncology: Insights from an Analysis of ClinicalTrials.gov DatabaseYu-Pei Chen, Jia-Wei Lv, Xu Liu, et al.
Theranostics|April 12, 2014
Polyglycerolsulfate functionalized gold nanorods as optoacoustic signal nanoamplifiers for in vivo bioimaging of rheumatoid arthritisJonathan Vonnemann, Nicolas Beziere, Christoph Böttcher, et al.
Theranostics|April 12, 2014
A novel tumor targeting drug carrier for optical imaging and therapyRui Li, Ke Zheng, Ping Hu, et al.
Theranostics|March 27, 2014
A synergistic therapeutic scheme for hyperglycemia and nephrotic disorders in diabetesQingyi He, Xing Zhang, Baosan Han, et al.
Theranostics|October 7, 2014
Glycoproteomic study reveals altered plasma proteins associated with HIV elite suppressorsWeiming Yang, Oliver Laeyendecker, Sarah K Wendel, et al.
Theranostics|October 7, 2014
Quantitative proteomics analysis identifies mitochondria as therapeutic targets of multidrug-resistance in ovarian cancerXiulan Chen, Shasha Wei, Ying Ma, et al.
Theranostics|October 7, 2014
MiR-194 deregulation contributes to colorectal carcinogenesis via targeting AKT2 pathwayHui-Jun Zhao, Lin-Lin Ren, Zhen-Hua Wang, et al.
Theranostics|October 7, 2014
Multidisciplinary efforts driving translational theranosticsTony Y Hu
Pageof 553

Showing results (521-530 of 5,522) with videos related to

Sort By:
Pageof 553
Theranostics|January 3, 2017
Comparison of <sup>68</sup>Ga-HBED-CC PSMA-PET/CT and multiparametric MRI for gross tumour volume detection in patients with primary prostate cancer based on slice by slice comparison with histopathologyConstantinos Zamboglou, Vanessa Drendel, Cordula A Jilg, et al.
Theranostics|January 3, 2017
Systemic siRNA Delivery with a Dual pH-Responsive and Tumor-targeted Nanovector for Inhibiting Tumor Growth and Spontaneous Metastasis in Orthotopic Murine Model of Breast CarcinomaBo Fan, Lin Kang, Liqing Chen, et al.
Theranostics|January 3, 2017
The Landscape of Clinical Trials Evaluating the Theranostic Role of PET Imaging in Oncology: Insights from an Analysis of ClinicalTrials.gov DatabaseYu-Pei Chen, Jia-Wei Lv, Xu Liu, et al.
Theranostics|April 12, 2014
Polyglycerolsulfate functionalized gold nanorods as optoacoustic signal nanoamplifiers for in vivo bioimaging of rheumatoid arthritisJonathan Vonnemann, Nicolas Beziere, Christoph Böttcher, et al.
Theranostics|April 12, 2014
A novel tumor targeting drug carrier for optical imaging and therapyRui Li, Ke Zheng, Ping Hu, et al.
Theranostics|March 27, 2014
A synergistic therapeutic scheme for hyperglycemia and nephrotic disorders in diabetesQingyi He, Xing Zhang, Baosan Han, et al.
Theranostics|October 7, 2014
Glycoproteomic study reveals altered plasma proteins associated with HIV elite suppressorsWeiming Yang, Oliver Laeyendecker, Sarah K Wendel, et al.
Theranostics|October 7, 2014
Quantitative proteomics analysis identifies mitochondria as therapeutic targets of multidrug-resistance in ovarian cancerXiulan Chen, Shasha Wei, Ying Ma, et al.
Theranostics|October 7, 2014
MiR-194 deregulation contributes to colorectal carcinogenesis via targeting AKT2 pathwayHui-Jun Zhao, Lin-Lin Ren, Zhen-Hua Wang, et al.
Theranostics|October 7, 2014
Multidisciplinary efforts driving translational theranosticsTony Y Hu
Pageof 553